Skip to main content

Table 6 Healthcare resource use during baseline and post-acute phasesa in the overall population and by age

From: Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19

Visit or Procedure

All Patients (N = 19,558)

Patients Aged 18–64 Years (n = 9381)

Patients Aged ≥ 65 Years (n = 10,177)

Baseline Phase

Post-Acute Phase

Change From Baseline to Post-Acute Phase, Δ (% Change)

Baseline Phase

Post-Acute Phase

Change From Baseline to Post-Acute Phase, Δ (% Change)

Baseline Phase

Post-Acute Phase

Change From Baseline to Post-Acute Phase, Δ (% Change)

Outpatient lab tests

 Tests, n

36,229

47,716

11,487 (31.7)

16,008

21,590

5582 (34.9)

20,221

26,126

5905 (29.2)

 Patients, n

12,453

13,565

1112 (8.9)

5809

6279

470 (8.1)

6644

7286

642 (9.7)

 Mean ± SD

1.9 ± 2.6

2.4 ± 3.3

0.6

1.7 ± 2.5

2.3 ± 3.2

0.6

2.0 ± 2.7

2.6 ± 3.3

0.6

 Median (Q1; Q3)

1 (0; 3)

1 (0; 3)

0

1 (0; 2)

1 (0; 3)

0

1 (0; 3)

2 (0; 4)

1

Outpatient visits (specialist or nonspecialist)

 Visits, n

488,305

613,201

124,896 (25.6)

190,988

235,557

44,569 (23.3)

297,317

377,644

80,327 (27.0)

 Patients, n

19,413

19,223

–190 (–1.0)

9357

9173

–184 (–2.0)

10,056

10,050

–6 (–0.1)

 Mean ± SD

25.0 ± 29.0

31.4 ± 36.3

6.4

20.4 ± 25.5

25.1 ± 30.5

4.8

29.2 ± 31.3

37.1 ± 40.1

7.9

 Median (Q1; Q3)

17 (9; 31)

20 (10; 39)

3

13 (7; 24)

16 (8; 31)

3

20 (11; 36)

26 (13; 47)

6

Emergency department visits

 Visits, n

11,168

9205

–1963 (–17.6)

5514

4418

–1096 (–19.9)

5654

4787

–867 (–15.3)

 Patients, n

5943

4756

–1187 (–20.0)

2830

2149

–681 (–24.1)

3113

2607

–506 (–16.3)

 Mean ± SD

0.6 ± 1.6

0.5 ± 1.9

–0.1

0.6 ± 1.9

0.5 ± 2.3

–0.1

0.6 ± 1.2

0.5 ± 1.3

–0.1

 Median (Q1; Q3)

0 (0; 1)

0 (0; 0)

0

0 (0; 1)

0 (0; 0)

0

0 (0; 1)

0 (0; 1)

0

Prescription classes

 Prescriptions, n

110,001

111,618

1617 (1.5)

49,424

48,329

–1095 (–2.2)

60,577

63,289

2712 (4.5)

 Patients, n

17,609

17,520

–89 (–0.5)

8795

8550

–245 (–2.8)

8814

8970

156 (1.8)

 Mean ± SD

5.6 ± 4.0

5.7 ± 4.1

0.1

5.3 ± 3.8

5.2 ± 4.0

–0.1

6.0 ± 4.1

6.2 ± 4.2

0.3

 Median (Q1; Q3)

5 (3; 8)

5 (3; 8)

0

5 (2; 7)

4 (2; 7)

–1

6 (3; 9)

6 (3; 9)

0

Inpatient visits

 Visits, n

3642

5301

1659 (45.6)

1314

1528

214 (16.3)

2328

3773

1445 (62.1)

 Patients, n

2523

2877

354 (14.0)

884

878

–6 (–0.7)

1639

1999

360 (22.0)

 Mean ± SD

0.2 ± 0.6

0.3 ± 0.9

0.1

0.1 ± 0.6

0.2 ± 0.8

0.0

0.2 ± 0.6

0.4 ± 1.0

0.1

 Median (Q1; Q3)

0 (0; 0)

0 (0; 0)

0

0 (0; 0)

0 (0; 0)

0

0 (0; 0)

0 (0; 0)

0

Inpatient lab tests

 Tests, n

851

1745

894 (105.1)

299

397

98 (32.8)

552

1348

796 (144.2)

 Patients, n

379

521

142 (37.5)

108

149

41 (38.0)

271

372

101 (37.3)

 Mean ± SD

0.0 ± 0.5

0.1 ± 1.0

0.1

0.0 ± 0.6

0.0 ± 0.6

0.0

0.1 ± 0.5

0.1 ± 1.3

0.1

 Median (Q1; Q3)

0 (0; 0)

0 (0; 0)

0

0 (0; 0)

0 (0; 0)

0

0 (0; 0)

0 (0; 0)

0

Length of hospital stay

 Days, n

18,941

50,310

31,369 (165.6)

7313

12,290

4977 (68.1)

11,628

38,020

26,392 (227.0)

 Patients, n

2523

2877

354 (14.0)

884

878

–6 (–0.7)

1639

1999

360 (22.0)

 Mean ± SD

7.5 ± 10.1

17.5 ± 25.2

10.0 (132.9)

8.3 ± 12.7

14.0 ± 25.9

5.7 (69.2)

7.1 ± 8.3

19.0 ± 24.8

11.9 (168.1)

 Median (Q1; Q3)

4 (3; 8)

8 (4; 21)

4

4 (3; 8)

5 (3; 13)

1

5 (3; 8)

9 (4; 24)

4

Length of ICU stay

 Days, n

937

1068

131 (14.0)

298

396

98 (32.9)

639

672

33 (5.2)

 Patients, n

742

743

1 (0.1)

214

217

3 (1.4)

528

526

–2 (–0.4)

 Mean ± SD

0.4 ± 0.7

0.4 ± 0.9

0.0 (0.0)

0.3 ± 0.8

0.5 ± 1.3

0.1 (33.8)

0.4 ± 0.7

0.3 ± 0.7

–0.1 (–13.8)

 Median (Q1; Q3)

0 (0; 1)

0 (0; 1)

0

0 (0; 0)

0 (0; 0)

0

0 (0; 1)

0 (0; 1)

0

Patients with invasive mechanical ventilation use, n (%)

165 (0.8)

210 (1.1)

45 (27.3)

58 (0.6)

75 (0.8)

17 (29.3)

107 (1.1)

135 (1.3)

28 (26.2)

Patients with noninvasive mechanical ventilation use, n (%)

147 (0.8)

173 (0.9)

26 (17.7)

51 (0.5)

60 (0.6)

9 (17.7)

96 (0.9)

113 (1.1)

17 (17.7)

Patients with supplemental oxygen use, n (%)

199 (1.0)

358 (1.8)

159 (79.9)

53 (0.6)

90 (1.0)

37 (69.8)

146 (1.4)

268 (2.6)

122 (83.6)

Patients with readmission within 30 days, n (%)

327 (1.7)

1144 (5.9)

817 (249.9)

131 (1.4)

220 (2.3)

89 (67.9)

196 (1.9)

924 (9.1)

728 (371.4)

  1. For visits, tests, prescriptions, and procedures, means or percentages were calculated using the total number of patients within the cohort as the denominator. For length of hospital stay and ICU stay, means were calculated as the total number of days divided by the number of patients with any inpatient hospital stay
  2. ICU intensive care unit, Q1 quartile 1, Q3 quartile 3
  3. aThe baseline period was the 12 months before the index date, and the post-acute phase spanned from 1 to 13 months after the index date